Syndecan-3
Syndecan-3 is a protein that in humans is encoded by the SDC3 gene. As a member of the syndecan proteoglycan family, Syndecan-3 plays a crucial role in cell proliferation, cell migration, and cell-matrix interactions. This protein is predominantly found in the nervous system and has significant implications in neuronal development and function.
Structure[edit | edit source]
Syndecan-3 is a type of heparan sulfate proteoglycan that is located on the cell surface. It consists of a core protein to which heparan sulfate glycosaminoglycan chains are attached. The core protein has a large extracellular domain, a single transmembrane domain, and a short cytoplasmic domain. The extracellular domain interacts with a variety of extracellular matrix proteins, growth factors, and other molecules, facilitating a wide range of cellular processes.
Function[edit | edit source]
The primary function of Syndecan-3 involves mediating cell adhesion and communication. It participates in the regulation of cell proliferation, differentiation, and migration, which are essential for tissue development and repair. In the nervous system, Syndecan-3 is involved in neuron development, axon guidance, and synaptic organization. It interacts with neurotrophic factors and other signaling molecules, influencing neuronal survival and plasticity.
Syndecan-3 also plays a role in the regulation of obesity and energy balance. It has been identified as a receptor for agouti-related protein (AgRP), a neuropeptide involved in the stimulation of food intake. This interaction suggests a potential mechanism through which Syndecan-3 influences metabolic processes and energy homeostasis.
Clinical Significance[edit | edit source]
Alterations in the expression or function of Syndecan-3 have been associated with various pathological conditions. In the context of cancer, Syndecan-3 can influence tumor growth and metastasis through its role in cell adhesion and migration. Its involvement in neuronal development and synaptic function also implicates it in neurological disorders, including neurodegenerative diseases and neuropathic pain.
Research into Syndecan-3 has also highlighted its potential as a therapeutic target. Modulating its activity or interactions could offer new approaches for treating obesity, cancer, and neurological disorders. However, further studies are necessary to fully understand its mechanisms of action and to develop effective therapeutic strategies.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD